114 related articles for article (PubMed ID: 8143855)
21. The potent mitogen Pasteurella multocida toxin is highly resistant to proteolysis but becomes susceptible at lysosomal pH.
Smyth MG; Pickersgill RW; Lax AJ
FEBS Lett; 1995 Feb; 360(1):62-6. PubMed ID: 7875303
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of the Pasteurella multocida toxin translocation domain.
Baldwin MR; Lakey JH; Lax AJ
Mol Microbiol; 2004 Oct; 54(1):239-50. PubMed ID: 15458419
[TBL] [Abstract][Full Text] [Related]
23. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
[TBL] [Abstract][Full Text] [Related]
24. Arf6-dependent intracellular trafficking of Pasteurella multocida toxin and pH-dependent translocation from late endosomes.
Repella TL; Ho M; Chong TP; Bannai Y; Wilson BA
Toxins (Basel); 2011 Mar; 3(3):218-41. PubMed ID: 22053287
[TBL] [Abstract][Full Text] [Related]
25. Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells.
Staddon JM; Chanter N; Lax AJ; Higgins TE; Rozengurt E
J Biol Chem; 1990 Jul; 265(20):11841-8. PubMed ID: 2365704
[TBL] [Abstract][Full Text] [Related]
26. Association of Pasteurella multocida toxin with vimentin.
Shime H; Ohnishi T; Nagao K; Oka K; Takao T; Horiguchi Y
Infect Immun; 2002 Nov; 70(11):6460-3. PubMed ID: 12379728
[TBL] [Abstract][Full Text] [Related]
27. Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs.
Foged NT
APMIS Suppl; 1992; 25():1-56. PubMed ID: 1576005
[No Abstract] [Full Text] [Related]
28. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
Kim TJ; Lee JI; Lee BJ
J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
[TBL] [Abstract][Full Text] [Related]
29. Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. involvement of Gq but not G11.
Zywietz A; Gohla A; Schmelz M; Schultz G; Offermanns S
J Biol Chem; 2001 Feb; 276(6):3840-5. PubMed ID: 11062245
[TBL] [Abstract][Full Text] [Related]
30. Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli.
Petersen SK; Foged NT
Infect Immun; 1989 Dec; 57(12):3907-13. PubMed ID: 2680987
[TBL] [Abstract][Full Text] [Related]
31. Characterization of toxin from different strains of Pasteurella multocida serotype A and D.
Frandsen PL; Foged NT; Petersen SK; Bording A
Zentralbl Veterinarmed B; 1991 Jul; 38(5):345-52. PubMed ID: 1927149
[TBL] [Abstract][Full Text] [Related]
32. Pasteurella multocida toxin activates Gbetagamma dimers of heterotrimeric G proteins.
Preuss I; Kurig B; Nürnberg B; Orth JH; Aktories K
Cell Signal; 2009 Apr; 21(4):551-8. PubMed ID: 19135527
[TBL] [Abstract][Full Text] [Related]
33. Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin.
Orth JH; Aktories K; Kubatzky KF
J Biol Chem; 2007 Feb; 282(5):3050-7. PubMed ID: 17150962
[TBL] [Abstract][Full Text] [Related]
34. Immunological roles of Pasteurella multocida toxin (PMT) using a PMT mutant strain.
Kim TJ; Toan NT; Jang EJ; Jung BG; Lee JI; Lee BJ
J Microbiol; 2007 Aug; 45(4):364-6. PubMed ID: 17846592
[TBL] [Abstract][Full Text] [Related]
35. Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.
Miyazawa M; Kitadokoro K; Kamitani S; Shime H; Horiguchi Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):906-8. PubMed ID: 16946476
[TBL] [Abstract][Full Text] [Related]
36. Pasteurella multocida toxin induces IL-6, but not IL-1 alpha or TNF alpha in fibroblasts.
Rosendal S; Frandsen PL; Nielsen JP; Gallily R
Can J Vet Res; 1995 Apr; 59(2):154-6. PubMed ID: 7648529
[TBL] [Abstract][Full Text] [Related]
37. Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.
Hildebrand D; Heeg K; Kubatzky KF
Infect Immun; 2011 Jan; 79(1):220-8. PubMed ID: 20956572
[TBL] [Abstract][Full Text] [Related]
38. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
Lee J; Woo HJ
J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
[TBL] [Abstract][Full Text] [Related]
39. Effects of the Pasteurella multocida toxin on osteoblastic cells in vitro.
Sterner-Kock A; Lanske B; Uberschär S; Atkinson MJ
Vet Pathol; 1995 May; 32(3):274-9. PubMed ID: 7604494
[TBL] [Abstract][Full Text] [Related]
40. Constitutive expression of Pasteurella multocida toxin.
Hoskins IC; Lax AJ
FEMS Microbiol Lett; 1996 Aug; 141(2-3):189-93. PubMed ID: 8768521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]